Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

532
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
532
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

405
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
405
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

451
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
451
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

531
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
531
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

247
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
247
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

419
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
419

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ready, Set, Coach: A Mixed Methods Pilot Study Exploring the Impact of Implementation Coaching to Optimize the Allied Health Assistant Workforce in Public Health Settings.

Journal of multidisciplinary healthcare·2026
Same author

Frequency and risk factors for tail injuries in UK dogs under primary veterinary care.

The Veterinary record·2025
Same author

A pilot RCT of virtual reality job interview training in transition-age youth on the autism spectrum.

Research in autism spectrum disorders·2025
Same author

A systematic review and meta-analysis of sex differences in the relationship between cardiac interoceptive accuracy and emotion.

Neuroscience and biobehavioral reviews·2025
Same author

Sureness of classification of breast cancers as pure ductal carcinoma <i>in situ</i> or with invasive components on dynamic contrast-enhanced magnetic resonance imaging: application of likelihood assurance metrics for computer-aided diagnosis.

Journal of medical imaging (Bellingham, Wash.)·2025
Same author

Multi-Level Approaches to Fetal Alcohol Spectrum Disorders Prevention Education and Training for Health Professionals.

Substance use & addiction journal·2024

Related Experiment Video

Updated: Jan 6, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
08:34

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Published on: November 18, 2018

7.6K

Pulmonary Hypertension and Pregnancy.

Stephanie R Martin1, Alexandra Edwards

  • 1Clinical Concepts in Obstetrics, Scottsdale, Arizona; and Division of Maternal Fetal Medicine, Saint Louis University, and Sound Physicians, SSM St. Mary's Hospital, St. Louis, Missouri.

Obstetrics and Gynecology
|October 11, 2019
PubMed
Summary

Pulmonary hypertension in pregnancy poses significant maternal risks. Early diagnosis and individualized, multidisciplinary care are crucial for managing this complex condition and improving outcomes.

More Related Videos

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

14.5K
Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice
10:20

Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice

Published on: January 16, 2013

25.9K

Related Experiment Videos

Last Updated: Jan 6, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
08:34

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Published on: November 18, 2018

7.6K
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

14.5K
Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice
10:20

Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice

Published on: January 16, 2013

25.9K

Area of Science:

  • Cardiology
  • Pulmonology
  • Obstetrics

Background:

  • Pulmonary hypertension (PH) is defined by elevated pulmonary artery pressure.
  • PH in pregnancy is linked to high maternal morbidity and mortality.
  • Accurate diagnosis, classification, and severity assessment guide treatment.

Purpose of the Study:

  • To review the natural history and outcomes of PH in pregnancy.
  • To discuss current evidence-based management strategies for pregnant patients with PH.
  • To highlight the importance of individualized, multidisciplinary care.

Main Methods:

  • Review of current literature on pulmonary hypertension in pregnancy.
  • Discussion of diagnostic tools, including echocardiography.
  • Summary of conventional and targeted therapeutic approaches.

Main Results:

  • Echocardiography is key for diagnosis and monitoring right heart function.
  • Management involves supportive care, conventional therapies, and targeted vasodilators for specific PH types.
  • Right heart failure management includes medical optimization, ECMO, and transplantation.

Conclusions:

  • Pregnancy management for PH requires individualized, multidisciplinary team approaches.
  • Further research is needed on delivery timing, mode, and anesthetic considerations.
  • Effective management aims to mitigate risks associated with PH during pregnancy.